Post-Brachytherapy Tumor Endoresection for Treatment of Toxic Maculopathy in Choroidal Melanoma

Eye - United Kingdom
doi 10.1038/eye.2013.115
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Endoresection With Adjuvant Ruthenium Brachytherapy for Selected Uveal Melanoma Patients - The Tuebingen Experience

Acta Ophthalmologica
MedicineOphthalmology
2016English

Transpupillary Thermotherapy of Choroidal Melanoma With or Without Brachytherapy: A Dilemma

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
1999English

Transpupillary Thermotherapy of Choroidal Melanoma With or Without Brachytherapy: A Dilemma

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
1999English

A Brief Editorial on Clinical Presentation and Treatment of Radiation Retinopathy Following Plaque Brachytherapy of Choroidal Melanoma

Journal of Clinical Research and Ophthalmology
2016English

Tumour-Lysis-Related Elevation of Intraocular Pressure Following High-Dose-Rate Brachytherapy for Choroidal Melanoma

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2004English

Intrascleral Recurrence of Uveal Melanoma After Transretinal "Endoresection"

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2001English

Toxic Maculopathy Due to Antimalarial Drugs

2020English

Ossification in Choroidal Melanoma.

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
1995English

Comparison of Iodide-125 and Ruthenium-106 Brachytherapy in the Treatment of Choroidal Melanomas

Clinical Ophthalmology
Ophthalmology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy